# FDA recall D-1030-2020

> **RemedyRepack Inc.** · Class II · drug recall initiated 2019-08-05.

## Product

Lisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 (Repackaged NDC for blister cards).

## Reason for recall

Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.

## Distribution

PA

## Key facts

- **Recall number:** D-1030-2020
- **Recalling firm:** RemedyRepack Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-08-05
- **Report date:** 2020-03-25
- **Termination date:** 2023-06-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Indiana, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1030-2020

## Citation

> AI Analytics. FDA recall D-1030-2020. Retrieved 2026-07-04 from https://api.ai-analytics.org/recall/D-1030-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*